The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global mechanical ventilators market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 7.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A mechanical ventilator is an artificial breathing device that is used for patients who are not able to breathe naturally during surgery or due to a critical illness. Some of the most commonly used product variants include positive and negative mechanical ventilators that are utilized in Intensive Care Units (ICUs), neonatal care centers and ambulances. These devices consist of a hollow tube that is inserted into the patient’s trachea to create a stable airway. They also assist in maintaining adequate levels of oxygen and carbon dioxide in the body to relieve respiratory distress, reverse respiratory muscle fatigue and initiate lung healing.
The increasing prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders is one of the key factors driving the growth of the market. Increasing geriatric population and number of individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), are further contributing to the market growth, as these people are more prone to respiratory disorders and COPD. Additionally, various technological advancements, including the development of portable and non-invasive mechanical ventilators, are driving the product adoption rates in both the developing and developed economies. Manufacturers are equipping these devices with high-speed signal processing systems and making improvements in the design, efficiency and safety measures of the equipment to make them more patient-friendly and cost-effective. Other factors, including improving healthcare infrastructure, rising awareness regarding the available treatments for respiratory diseases and extensive research and development (R&D) activities, are projected to drive the market further.
Breakup by Product Type:
Breakup by Interface:
Breakup by Age Group:
Breakup by Mode of Ventilation:
Breakup by End-Use:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co. KG (Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc, Vyaire Medical Inc., etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Interface, Age Group, Mode of Ventilation, End-Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co. KG (Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc and Vyaire Medical Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at